| Product Code: ETC9680878 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market - Industry Life Cycle |
3.4 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market - Porter's Five Forces |
3.5 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume Share, By Component, 2021 & 2031F |
3.6 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume Share, By Analytical Method, 2021 & 2031F |
3.7 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume Share, By Process, 2021 & 2031F |
3.8 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in cell and gene therapy research and development in Thailand |
4.2.2 Growing demand for quality control measures to ensure safety and efficacy of cell and gene therapy products |
4.2.3 Favorable regulatory environment supporting the growth of the cell and gene therapy sector in Thailand |
4.3 Market Restraints |
4.3.1 Lack of standardized quality control protocols and guidelines in the cell and gene therapy manufacturing industry in Thailand |
4.3.2 Limited access to advanced technologies and expertise for quality control processes |
4.3.3 High costs associated with implementing quality control measures in cell and gene therapy manufacturing facilities |
5 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market Trends |
6 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market, By Types |
6.1 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market, By Component |
6.1.1 Overview and Analysis |
6.1.2 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Component, 2021- 2031F |
6.1.3 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Equipment & Accessories, 2021- 2031F |
6.1.4 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Consumables, 2021- 2031F |
6.1.5 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market, By Analytical Method |
6.2.1 Overview and Analysis |
6.2.2 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Sterility Testing, 2021- 2031F |
6.2.3 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Purity Testing, 2021- 2031F |
6.2.4 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Potency Testing, 2021- 2031F |
6.2.5 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Identity Testing, 2021- 2031F |
6.2.6 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market, By Process |
6.3.1 Overview and Analysis |
6.3.2 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Upstream Processes, 2021- 2031F |
6.3.3 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Downstream Processes, 2021- 2031F |
6.3.4 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Process Development, 2021- 2031F |
6.4 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market, By End-user |
6.4.1 Overview and Analysis |
6.4.2 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.4.3 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Contract Manufacturing Organizations, 2021- 2031F |
7 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market Import-Export Trade Statistics |
7.1 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market Export to Major Countries |
7.2 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market Imports from Major Countries |
8 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market Key Performance Indicators |
8.1 Percentage of cell and gene therapy manufacturing facilities in Thailand implementing quality control best practices |
8.2 Number of collaborations between research institutions and industry players for developing quality control standards |
8.3 Adoption rate of emerging technologies for quality control in the cell and gene therapy manufacturing sector in Thailand |
9 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market - Opportunity Assessment |
9.1 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market Opportunity Assessment, By Component, 2021 & 2031F |
9.2 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market Opportunity Assessment, By Analytical Method, 2021 & 2031F |
9.3 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market Opportunity Assessment, By Process, 2021 & 2031F |
9.4 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market - Competitive Landscape |
10.1 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenue Share, By Companies, 2024 |
10.2 Thailand Cell and Gene Therapy Manufacturing Quality Control (QC) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here